By InvitationNot Applicable

Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.

China300 participantsStarted 2024-03-01

Plain-language summary

Shingles is a neuropathic disease caused by varicella-herpes virus(VZV) invading nerves and accompanying pain.Currently, the treatment of postherpetic neuralgia (PHN) includes medication and minimally invasive interventional therapy.In patients with herpes zoster neuralgia treated with spinal cord stimulation (SCS), some patients have satisfactory pain relief after surgery, but some patients have pain symptoms again some time after surgery. The reason for this difference in treatment effect is not clear.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years old. * NRS score ≥4 points. * The pain NRS of previous shingles area treated with SCS was ≤3, and the pain NRS was \> 4 after recurrence. Exclusion Criteria: * Serious cardiovascular and cerebrovascular diseases, such as heart failure, intracranial aneurysm, hypertension (high risk, very high risk). * Epilepsy, suffering from mental illness. * And patients who were lost to follow-up.

What they're measuring

Pain recurrence

Timeframe: up to 1 year

Trial details

NCT IDNCT06410222

SponsorFeng Gao

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-02-02

View on ClinicalTrials.gov More Post Herpetic Neuralgia trials